'Drug supply' diaporamas de présentation

Drug supply - PowerPoint PPT Presentation

Controlled Substance Management or “Doctor I need Oxy”

Controlled Substance Management or “Doctor I need Oxy”

Tony Tommasello, Ph.D. University of Maryland School of Pharmacy Office of Substance Abuse Studies 410 706-7513 atommase@rx.umaryland.edu. Controlled Substance Management or “Doctor I need Oxy”. Program Objectives. At the end of this program participants will be better able to:

★ ★ ★ ★ ★

953 views • 79 slides
The Power of Integrated Supply Chains, by Design

The Power of Integrated Supply Chains, by Design

The Power of Integrated Supply Chains, by Design. International GMP Conference University of Georgia, March 14 2012 Presented by: Hedley Rees, Managing Director Biotech PharmaFlow. AGENDA. Why am I so passionate about the Pharma supply chain? How did it get into all this trouble?

★ ★ ★ ★ ★

601 views • 41 slides
Quality Control of Medicines and Organization of Market Surveillance in Kenya

Quality Control of Medicines and Organization of Market Surveillance in Kenya

3-5a. Quality Control of Medicines and Organization of Market Surveillance in Kenya. Dr. H. K. Chepkwony, PhD Director, National Quality Control Laboratory (NQCL); Kenya.

★ ★ ★ ★ ★

2.62k views • 39 slides
Securing an Adequate Drug Supply for each TB Patient

Securing an Adequate Drug Supply for each TB Patient

Securing an Adequate Drug Supply for each TB Patient. Jennifer Flood MD, MPH University of California, San Francisco Jennifer.Flood@cdph.ca.gov. Essential Components of a National TB Program. International Standards for TB Control programs

★ ★ ★ ★ ★

538 views • 33 slides
Cuyuna Regional Medical Center’s Drug/Alcohol Free Workplace and Testing Policy

Cuyuna Regional Medical Center’s Drug/Alcohol Free Workplace and Testing Policy

Cuyuna Regional Medical Center’s Drug/Alcohol Free Workplace and Testing Policy. Welcome…. Let’s learn about Cuyuna Regional Medical Center’s Drug-Free Workplace and Testing and Diversion Prevention Policies. Purpose.

★ ★ ★ ★ ★

511 views • 32 slides
Good Distribution Practices: What do they mean to you?

Good Distribution Practices: What do they mean to you?

Good Distribution Practices: What do they mean to you?. Presented by: Hedley Rees, Biotech PharmaFlow , UK. Agenda. Distribution in Pharmaceuticals Why has GDP become such a hot topic? What is the current global landscape? What are the issues and opportunities? Q&A session.

★ ★ ★ ★ ★

2.42k views • 26 slides
Controversy? What controversy? An attempt to structure the debate on adaptive designs

Controversy? What controversy? An attempt to structure the debate on adaptive designs

Controversy? What controversy? An attempt to structure the debate on adaptive designs. Marc Vandemeulebroecke MCP, Vienna, 11.7.2007. Vandemeulebroecke Controversy? What controversy? 1. Examples (1): Sequential analysis.

★ ★ ★ ★ ★

600 views • 20 slides
FDA Pediatric Oncology Subcommittee Meeting

FDA Pediatric Oncology Subcommittee Meeting

FDA Pediatric Oncology Subcommittee Meeting. “Company Perspective”. Key Questions to Address (Company Perspective). Question #1-When in the development of a new oncolytic should pediatric studies be undertaken?

★ ★ ★ ★ ★

368 views • 17 slides
The Peterson Group and WHO to Fight against Drug Counterfeit

The Peterson Group and WHO to Fight against Drug Counterfeit

Described as the crime of the 21st century, the counterfeiting of drugs is a common problem that plagues the governments and manufacturers in Asia. Of all the counterfeiting methods there are, none are more potentially damaging than those affecting health and safety. The production, distribution and consumption of counterfeit and fraud medicines are worldwide and affecting greatly not only in Asia which poses the biggest manufacturers of counterfeits but also to the countries where the drugs has been distributed. According to the World Health Organization (WHO), a significant fraction of the world’s drug supply is counterfeit and falsified. Estimates of counterfeit drugs range from 10 to 15 % for the world drug supply, to more than 25% in developing countries (Gibson, 2004).

★ ★ ★ ★ ★

325 views • 17 slides
Management of Uterotonic medicines for use in the prevention of post-partum hemorrhage

Management of Uterotonic medicines for use in the prevention of post-partum hemorrhage

Management of Uterotonic medicines for use in the prevention of post-partum hemorrhage. Grace Adeya, SPS/MSH. Dimensions of Access to Medicines. Framework for improving access. Availability: Management of Drug Supply. Availability: Background of knowledge of key personnel.

★ ★ ★ ★ ★

303 views • 16 slides
First European conference on drug supply indicators, 20-22 .10.2010, Brussels – Feed-back

First European conference on drug supply indicators, 20-22 .10.2010, Brussels – Feed-back

First European conference on drug supply indicators, 20-22 .10.2010, Brussels – Feed-back. Chloé Carpentier , Laurent Laniel, EMCDDA 33 rd meeting of the EMCDDA Scientific Committee 16th November 2010. Background. EU Drug Action Plan 2009-2012, Action 67:

★ ★ ★ ★ ★

260 views • 15 slides
By Dr. Elizabeth Ominde-Ogaja, Dr. Gunter Boussery and Dr. George Otieno

By Dr. Elizabeth Ominde-Ogaja, Dr. Gunter Boussery and Dr. George Otieno

Improving Access to Essential Medicines in Kenya: The Nyamira District Revolving Drug Fund Experience:. By Dr. Elizabeth Ominde-Ogaja, Dr. Gunter Boussery and Dr. George Otieno. Abstract.

★ ★ ★ ★ ★

356 views • 14 slides
Standard Treatments

Standard Treatments

Standard Treatments. Standard Treatments: Objectives. Recognize and convey to others the advantages and benefits of standard treatments in promoting drug use Develop effective, economic, and appropriate treatment protocols for priority health problems

★ ★ ★ ★ ★

214 views • 14 slides
Standard Treatments

Standard Treatments

Standard Treatments. Standard Treatments: Objectives. Recognize and convey to others the advantages and benefits of standard treatments in promoting drug use Develop effective, economic, and appropriate treatment protocols for priority health problems

★ ★ ★ ★ ★

156 views • 14 slides
County Lines

County Lines

County Lines.

★ ★ ★ ★ ★

144 views • 12 slides
County Lines

County Lines

County Lines.

★ ★ ★ ★ ★

254 views • 12 slides
Stop TB Strategy Planning Frameworks

Stop TB Strategy Planning Frameworks

Stop TB Strategy Planning Frameworks. Mukund Uplekar TB Strategy, Operations and Health Systems, Stop TB Department, WHO. Planning framework: what is it? . Tool(s) to help translate the new Stop TB Strategy into GFATM proposal form for Round Six applications . Planning framework format.

★ ★ ★ ★ ★

384 views • 10 slides
impact of counterfeits on pharmaceutical industry

impact of counterfeits on pharmaceutical industry

Counterfeiting in Pharmaceuticals has become a Global Program and Almost no Country is Immune to it

★ ★ ★ ★ ★

310 views • 6 slides
Cross-Border Internet Pharmacy: No Place to Buy Drugs

Cross-Border Internet Pharmacy: No Place to Buy Drugs

Cross-Border Internet Pharmacy: No Place to Buy Drugs. Durhane Wong-Rieger, PhD Consumer Advocare Network. Importation and the Safety of the Drug Supply Chain. Government agencies in Canada and the United States will not attest to the safety of drugs re-imported into the United States.

★ ★ ★ ★ ★

186 views • 6 slides
15 June 2009 EMCDDA activities ~ Supply Reduction

15 June 2009 EMCDDA activities ~ Supply Reduction

15 June 2009 EMCDDA activities ~ Supply Reduction. Laurent Laniel Interventions, Law and Policies (‘RES’) Unit, CUP-DSSR. EMCDDA so far (1), routinely…. Monitors drug supply and markets (NFPs):

★ ★ ★ ★ ★

178 views • 6 slides

View Drug supply PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Drug supply PowerPoint presentations. You can view or download Drug supply presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.